SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-079026 from Haoxi Health Technology Ltd (HAO)

Haoxi Health Technology Ltd
Date: Sept. 16, 2024 · CIK: 0001954594 · Accession: 0001213900-24-079026

AI Filing Summary & Sentiment

File numbers found in text: 333-280174

Date
September 16, 2024
Author
Haoxi Health Technology Limited
Form
CORRESP
Company
Haoxi Health Technology Ltd

Letter

Haoxi Health Technology Limited

September 16, 2024

Via EDGAR

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

Attention: Nicholas Nalbantian

Dietrich King

Re: Haoxi Health Technology Limited

Registration Statement on Form F-1, as amended

Initially Filed on June 13, 2024

File No. 333-280174

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Haoxi Health Technology Limited hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, be accelerated to and that the Registration Statement become effective at 5:30 p.m., Eastern Time, on September 18, 2024, or as soon thereafter as practicable.

Very truly yours,
Haoxi Health Technology Limited

Show Raw Text
CORRESP
1
filename1.htm

Haoxi Health Technology Limited

September 16, 2024

Via EDGAR

Division of Corporation Finance

Office of Manufacturing

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

    Attention:
    Nicholas Nalbantian

    Dietrich King

    Re:
    Haoxi Health Technology Limited

    Registration Statement on Form F-1, as amended

    Initially Filed on June 13, 2024

    File No. 333-280174

Ladies and Gentlemen:

In accordance with Rule 461
of the General Rules and Regulations under the Securities Act of 1933, as amended, Haoxi Health Technology Limited hereby requests
that the effectiveness of the above-referenced Registration Statement on Form F-1, as amended, be accelerated to and that the Registration
Statement become effective at 5:30 p.m., Eastern Time, on September 18, 2024, or as soon thereafter as practicable.

    Very truly yours,

    Haoxi Health Technology Limited

    By:
    /s/ Fan Zhen

    Name:
    Fan Zhen

    Title:
    Chief Executive Officer, Director